Skip to main content
Ching-Wei Tzeng, MD, General Surgery, Houston, TX

Ching-Wei David Tzeng MD FACS

Hepatobiliary Surgery, Pancreas


Associate Professor

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

  • Fax+1 713-745-1921

Dr. Tzeng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, HPB Surgery, 2012 - 2013
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2010 - 2012
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Surgery, 2003 - 2010
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2005 - 2025
  • Surgery
    American Board of Surgery Surgery
  • Join now to see all

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery  
    Ryan W Day, Timothy E Newhook, Ching-Wei D Tzeng, JAMA Surgery
  • Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma  
    Shubham Pant, Milind Javle, Naruhiko Ikoma, Ching-Wei Tzeng, Jeffrey E Lee, JAMA Surgery

Authored Content

  • Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
  • Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020

Press Mentions

  • Opioid-Free Discharge Feasible After Pancreatectomy
    Opioid-Free Discharge Feasible After PancreatectomySeptember 9th, 2023
  • Liver Regeneration: How the Liver’s Ability to Recover Plays into Liver Cancer Surgery
    Liver Regeneration: How the Liver’s Ability to Recover Plays into Liver Cancer SurgeryNovember 2nd, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: